Filtered By:
Specialty: Orthopaedics
Condition: Arrhythmia
Countries: France Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
No impact of anti-Rank ligand and PTH analogs on cardiovascular risk in postmenopausal osteoporosis: a systematic literature review and meta-analysis
ConclusionsThe anti-Rank ligand and PTH analogs have no impact on cardiovascular risk and overall mortality in idiopathic osteoporosis. To better answer the question whether these treatments can reduce the long-term cardiovascular risk, further comparative studies with longer duration are required.
Source: Archives of Orthopaedic and Trauma Surgery - January 2, 2020 Category: Orthopaedics Source Type: research
